155 related articles for article (PubMed ID: 37085395)
21. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
[TBL] [Abstract][Full Text] [Related]
22. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
23. Malignant phyllodes tumor of the breast: a systematic review.
Lissidini G; Mulè A; Santoro A; Papa G; Nicosia L; Cassano E; Ashoor AA; Veronesi P; Pantanowitz L; Hornick JL; Rossi ED
Pathologica; 2022 Apr; 114(2):111-120. PubMed ID: 35414723
[TBL] [Abstract][Full Text] [Related]
24. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
Lee AH; Hodi Z; Ellis IO; Elston CW
Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
[TBL] [Abstract][Full Text] [Related]
25. Fibroepithelial lesions of the breast: a comprehensive morphological and outcome analysis of a large series.
Slodkowska E; Nofech-Mozes S; Xu B; Parra-Herran C; Lu FI; Raphael S; Zubovits J; Hanna W
Mod Pathol; 2018 Jul; 31(7):1073-1084. PubMed ID: 29449684
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
27. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
[TBL] [Abstract][Full Text] [Related]
28. Recurrent challenges in the evaluation of fibroepithelial lesions.
Giri D
Arch Pathol Lab Med; 2009 May; 133(5):713-21. PubMed ID: 19415945
[TBL] [Abstract][Full Text] [Related]
29. Periductal Stromal Tumor of the Breast with a
Anderson B; Marotti JD; Lefferts JA; Muller KE
Int J Surg Pathol; 2023 Dec; 31(8):1626-1631. PubMed ID: 36823780
[TBL] [Abstract][Full Text] [Related]
30. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
31. Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012.
Tan PH; Ellis IO
J Clin Pathol; 2013 Jun; 66(6):465-70. PubMed ID: 23533258
[TBL] [Abstract][Full Text] [Related]
32. Validation of the Singapore nomogram for outcome prediction in breast phyllodes tumours in a large patient cohort.
Chng TW; Gudi M; Lim SH; Li H; Tan PH
J Clin Pathol; 2018 Feb; 71(2):125-128. PubMed ID: 28751520
[TBL] [Abstract][Full Text] [Related]
33. A Diagnostic Approach to Fibroepithelial Breast Lesions.
Tan BY; Tan PH
Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
[TBL] [Abstract][Full Text] [Related]
34. Morphological features of 52 cases of breast phyllodes tumours with local recurrence.
Bi J; Tang H; Lin X; Yu X; Liang Y; Zhang L; Li Z; Shao M
Virchows Arch; 2022 Oct; 481(4):519-531. PubMed ID: 35906487
[TBL] [Abstract][Full Text] [Related]
35. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
[TBL] [Abstract][Full Text] [Related]
36. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
Resetkova E; Khazai L; Albarracin CT; Arribas E
Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
[TBL] [Abstract][Full Text] [Related]
37. Atypia in breast pathology: what pathologists need to know.
Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
[TBL] [Abstract][Full Text] [Related]
38. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
Jara-Lazaro AR; Akhilesh M; Thike AA; Lui PC; Tse GM; Tan PH
Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
[TBL] [Abstract][Full Text] [Related]
39. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
Feakins RM; Mulcahy HE; Nickols CD; Wells CA
Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
[TBL] [Abstract][Full Text] [Related]
40. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
